GlassScriptPhysician profile
Matthew B Mills
NPI 1407843782
$14,785.22
in general payments reported to CMS, 2019-2025
32 companies · $5,852 in 2025
The $5,852 reported for 2025 was more than what 94% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,398 · 2020: $652 · 2021: $1,442 · 2022: $2,292 · 2023: $1,267 · 2024: $1,882 · 2025: $5,852.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,673 · Consulting Fee: $4,000 · Travel and Lodging: $303 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,672.82 |
| Consulting Fee | $4,000.00 |
| Travel and Lodging | $302.81 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $6,587.13 | 2019-2025 | Lensx, Ora System Verifeye, Clareon |
| Glaukos Corporation | $1,951.59 | 2019-2025 | Idosetr, Idose, Istent Trabecular Micro-Bypass System Model Is3 |
| Rayner Intraocular Lenses Limited | $1,097.17 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $777.17 | 2019-2023 | Tecnis Simplicity |
| Sight Sciences, INC. | $534.58 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Abbvie INC. | $418.19 | 2022-2024 | |
| Carl Zeiss Meditec USA, INC. | $400.87 | 2021-2024 | |
| Sun Pharmaceutical Industries INC. | $313.98 | 2019-2025 | Cequa |
| Oyster Point Pharma, INC. | $306.47 | 2023-2025 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $294.69 | 2019-2023 | |
| Allergan, INC. | $263.30 | 2019-2022 | |
| Biotissue Holdings INC. | $198.45 | 2022-2025 | |
| Aerie Pharmaceuticals, INC. | $184.38 | 2019-2021 | |
| Rxsight INC | $175.22 | 2021-2025 | Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Apellis Pharmaceuticals, INC. | $156.75 | 2024-2025 | Syfovre |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ocular Therapeutix, INC. | $151.01 | 2024 | Dextenza |
| Mallinckrodt Hospital Products INC. | $144.54 | 2023-2025 | Acthar |
| Horizon Therapeutics Plc | $124.72 | 2021 | |
| Hoffmann-La Roche Limited | $99.00 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $88.14 | 2019-2021 | |
| Omeros Corporation | $66.99 | 2019-2021 | |
| Dompe US, INC. | $61.47 | 2021-2025 | Oxervate |
| Astellas Pharma US INC | $56.57 | 2024 | Izervay |
| Ivantis, INC | $51.22 | 2020-2021 | |
| Kala Pharmaceuticals, INC. | $51.15 | 2019-2021 | |
| New World Medical,INC. | $47.49 | 2021-2022 | |
| Bausch & Lomb Americas INC. | $45.11 | 2023-2025 | Scoutpro Osmolarity System, Vyzulta |
| Ani Pharmaceuticals, INC. | $44.79 | 2024-2025 | Purified Cortrophin Gel |
| Alcon Research LLC | $37.12 | 2021 | |
| Harrow Eye, LLC | $20.64 | 2025 | |
| Eyevance Pharmaceuticals LLC | $20.48 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $14.84 | 2024 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Mills listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.